These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32910333)

  • 21. The associated impact of standardized admission screening on vancomycin-resistant
    Pfister TR; Chow B; Shen Y; Ellison J; Bush K
    Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1289-1293. PubMed ID: 36200345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.
    Tan D; Htun HL; Koh J; Kanagasabai K; Lim JW; Hon PY; Ang B; Chow A
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
    Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia.
    Fox E; Ha D; Bounthavong M; Meng L; Mui E; Holubar M; Deresinski S; Alegria W
    BMC Infect Dis; 2022 Nov; 22(1):855. PubMed ID: 36384497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
    Lautenbach E; Bilker WB; Brennan PJ
    Infect Control Hosp Epidemiol; 1999 May; 20(5):318-23. PubMed ID: 10349947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
    Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
    Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia.
    Butler-Laporte G; Cheng MP; McDonald EG; Lee TC
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):425-429. PubMed ID: 31973783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin-resistant enterococci colonization in a neonatal intensive care unit: who will be infected?
    Akturk H; Sutcu M; Somer A; Acar M; Akgun Karapınar B; Aydin D; Cihan R; Ince Z; Çoban A; Salman N
    J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3478-82. PubMed ID: 26744145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.
    Ford CD; Lopansri BK; Haydoura S; Snow G; Dascomb KK; Asch J; Bo Petersen F; Burke JP
    Infect Control Hosp Epidemiol; 2015 Jan; 36(1):47-53. PubMed ID: 25627761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
    Banach DB; Peaper DR; Fortune BE; Emre S; Dembry LM
    Clin Transplant; 2016 Mar; 30(3):306-11. PubMed ID: 26780305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative daptomycin for prophylaxis of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
    Mak JT; Ha S; Perloff S; Knorr JP
    Transpl Infect Dis; 2024 Feb; 26(1):e14186. PubMed ID: 37910593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.
    Ford CD; Lopansri BK; Gazdik MA; Snow GL; Webb BJ; Konopa KL; Petersen FB
    Transpl Infect Dis; 2015 Oct; 17(5):688-94. PubMed ID: 26256692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.
    Papadimitriou-Olivgeris M; Drougka E; Fligou F; Kolonitsiou F; Liakopoulos A; Dodou V; Anastassiou ED; Petinaki E; Marangos M; Filos KS; Spiliopoulou I
    Infection; 2014 Dec; 42(6):1013-22. PubMed ID: 25143193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia.
    Aslam W; Mathew NE; Shaver C; Brito V; Jones S; Arroliga AC; Ghamande S
    Am J Ther; 2020 Sep; 28(4):e388-e396. PubMed ID: 32909964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic options for vancomycin-resistant enterococcal bacteremia.
    Barber KE; King ST; Stover KR; Pogue JM
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):363-77. PubMed ID: 25661903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attributable mortality of vancomycin resistance in ampicillin-resistant
    Rottier WC; Pinholt M; van der Bij AK; Arpi M; Blank SN; Nabuurs-Franssen MH; Ruijs GJHM; Tersmette M; Ossewaarde JM; Groenwold RH; Westh H; Bonten MJM; ;
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):719-727. PubMed ID: 35670618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.